scispace - formally typeset
J

J. P. de Vos

Publications -  11
Citations -  361

J. P. de Vos is an academic researcher. The author has contributed to research in topics: Carboplatin & Lomustine. The author has an hindex of 6, co-authored 11 publications receiving 300 citations.

Papers
More filters
Journal ArticleDOI

European consensus document on mast cell tumours in dogs and cats.

TL;DR: Current information on canine and feline mast cell disease was gathered from international studies and a emphasis was placed on material and opinion with a strong evidence base to form the basis of understanding in this disease at the current time.
Journal ArticleDOI

Piroxicam and carboplatin as a combination treatment of canine oral non-tonsillar squamous cell carcinoma: a pilot study and a literature review of a canine model of human head and neck squamous cell carcinoma.

TL;DR: The results of the treatment with a combination of carboplatin and piroxicam in seven dogs with advanced non-tonsillar oral squamous cell carcinoma suggest that this multiagent approach is a useful treatment option for oral non-TONSillar SCC in dogs and warrants wider application.
Journal ArticleDOI

Comparison between symptomatic treatment and lomustine supplementation in 71 dogs with intracranial, space-occupying lesions.

TL;DR: Age, duration of symptoms, intracranial localization of the mass and intra- or extra-axial localization had no influence on survival time, however, female dogs survived significantly longer than male dogs.
Journal ArticleDOI

Canine tonsillar squamous cell carcinoma – a multi-centre retrospective review of 44 clinical cases

TL;DR: Dogs with tonsillar squamous cell carcinoma that suffered anorexia and lethargy had shorter survival times than patients without these clinical signs, and there is no highly effective treatment for canine tonsillary squamouscell carcinoma.
Journal ArticleDOI

Primary frontal sinus squamous cell carcinoma in three dogs treated with piroxicam combined with carboplatin or toceranib

TL;DR: This is the first publication concerning canine pFS-SCC, diagnosed using histology or cytology and medical imaging, in three dogs, and a significant tumour reduction occurred, but the dog was euthanized after 195 days because of a relapse.